|
LOC651250 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.39319999770527E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.30215846386272E-12 |
| Normal-vs-Stage2 |
1.283920E-03 |
| Normal-vs-Stage3 |
2.916500E-03 |
| Normal-vs-Stage4 |
2.414600E-01 |
| Stage1-vs-Stage2 |
2.674000E-01 |
| Stage1-vs-Stage3 |
1.194900E-04 |
| Stage1-vs-Stage4 |
1.04460000005524E-06 |
| Stage2-vs-Stage3 |
1.659790E-01 |
| Stage2-vs-Stage4 |
2.224400E-02 |
| Stage3-vs-Stage4 |
1.484000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.87590004535809E-09 |
| Normal-vs-AfricanAmerican |
5.023800E-02 |
| Normal-vs-Asian |
2.614000E-02 |
| Caucasian-vs-AfricanAmerican |
7.564400E-02 |
| Caucasian-vs-Asian |
1.931360E-01 |
| AfricanAmerican-vs-Asian |
4.928400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08759999994934E-06 |
| Normal-vs-Female |
3.13040038335544E-10 |
| Male-vs-Female |
2.289800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.161800E-02 |
| Normal-vs-Age(41-60Yrs) |
6.71459998713431E-09 |
| Normal-vs-Age(61-80Yrs) |
1.03620000002635E-06 |
| Normal-vs-Age(81-100Yrs) |
9.618400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.821000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.981600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.269800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.344040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.625000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.589600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.59480223366404E-11 |
| Normal-vs-Grade 2 |
2.43671749444729E-12 |
| Normal-vs-Grade 3 |
3.43690000004226E-06 |
| Normal-vs-Grade 4 |
6.709200E-01 |
| Grade 1-vs-Grade 2 |
1.261710E-02 |
| Grade 1-vs-Grade 3 |
1.823440E-04 |
| Grade 1-vs-Grade 4 |
8.49339998332255E-09 |
| Grade 2-vs-Grade 3 |
1.717390E-03 |
| Grade 2-vs-Grade 4 |
4.33630020779674E-10 |
| Grade 3-vs-Grade 4 |
3.99730000000265E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
2.937600E-03 |
| ccA subtype-vs-ccB subtype |
1.89670001926601E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.79849999524396E-08 |
| Normal-vs-N1 |
3.913600E-01 |
| N0-vs-N1 |
2.663400E-01 |
|
|
